Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q4 2021 vs. Q3 2021
How the institutions holding Alterity Therapeutics Ltd changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 14 | 11 | −3 |
| Shares | 638.4K | 752.7K | +114.3K (+17.9%) |
| Value | $808.1K | $541.0K | −$267.1K (−33.1%) |
New holders (4)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Envestnet Asset Management Inc | 82,386 | $59.0K | 0.00% |
| Susquehanna International Group, LLP | 61,585 | $44.0K | 0.00% |
| UBS Group AG | 13,599 | $10.0K | 0.00% |
| CoreCap Advisors, LLC | 216 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Alterity Therapeutics Ltd at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Citadel Advisors LLC | 11,761 | $15.0K |
| Virtu Financial LLC | 11,351 | $14.0K |
| HRT Financial LP | 10,610 | $13.0K |
| Wells Fargo & Company | 2,500 | $3.00K |
| Optimum Investment Advisors | 927 | $1.00K |
| Geneos Wealth Management Inc. | 1,167 | $1.00K |
| American Portfolios Advisors | 83 | $105 |